Is CBD Legal in Israel?
August 6, 2026
CBD in Israel remains restricted in 2026: the 2022 plan to remove it from the Dangerous Drugs Ordinance was never implemented. Gray-market sales are tolerated.
CBD in Israel remains restricted in 2026: the 2022 plan to remove it from the Dangerous Drugs Ordinance was never implemented. Gray-market sales are tolerated.
CBD remains technically restricted in Israel. In February 2022 the Ministry of Health announced that cannabidiol would be removed from the Dangerous Drugs Ordinance and that CBD products containing less than 0.3% THC should be excluded from controlled-substance rules (raising the prior 0.2% threshold), but the reclassification was never fully implemented. As of August 2026, CBD has not been formally deleted from the Ordinance, and over-the-counter sale of CBD supplements, foods, and oils is still not authorized. A Ministry of Health expert panel also recommended against permitting CBD in foodstuffs, supplements, and cosmetics pending further review.
In practice a tolerated gray market operates: enforcement against consumers is not a police priority, Israeli courts have been sympathetic to purchasers of low-THC CBD products, and personal imports frequently clear customs. CBD-containing pharmaceutical products (such as Epidiolex for refractory epilepsy) remain available on prescription, and CBD-dominant medical cannabis preparations are dispensed under IMCA oversight. Marketing health claims for non-pharmaceutical CBD products is restricted under Ministry of Health consumer protection rules.
Last reviewed: August 6, 2026.
Restricted
IMCA, Ministry of Health
Proposed 0.3% THC threshold for declassified CBD products (not yet implemented)
Dangerous Drugs Ordinance; February 2022 Ministry of Health decision to declassify CBD (implementation pending)
Commercial import of CBD products remains subject to Dangerous Drugs Ordinance controls and Ministry of Health licensing because the 2022 declassification decision has not been implemented, so CBD is not cleared as an ordinary consumer good. Personal-use packages from abroad are frequently tolerated by customs in practice but lack formal legal protection. Products containing measurable THC fall under IMCA's medical cannabis import-export licensing framework.
